Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2

Haematologica

Volumn 94, Issue 2, 2009, Pages 276-279

  Pelucchi, Sara ^a,b   Mariani, Raffaella ^b,c   Trombini, Paola ^c   Coletti, Sabina ^b,c   Pozzi, Matteo ^b,c   Paolini, Valentina ^b,c   Barisani, Donatella ^b   Piperno, Alberto ^a,b,c  

^a Consortium for Human Molecular Genetics ^*  (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Hepatic expression; Hepcidin; Iron overload; Splicing mutation; TFR2

Indexed keywords

DNA; FERROUS SULFATE; HEPCIDIN; TRANSFERRIN RECEPTOR 2;

ADULT; ARTICLE; CASE REPORT; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HEMOCHROMATOSIS; HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; GENE EXPRESSION PROFILING; HEMOCHROMATOSIS; HUMANS; MIDDLE AGED; MUTATION; RECEPTORS, TRANSFERRIN;

EID: 59449107280     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13576     Document Type: Article

References (24)

1. Wallace DF, Subramaniam VN. Non-HFE haemochromatosis. World J Gastroenterol 2007;13:4690-8.
2. Drake SF, Morgan EH, Herbison CE, Delima R, Graham RM, Chua ACG et al. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 2007;292:G323-8.
3. Wallace DF, Summerville L, Lusby PE, Subramaniam VN. First phenotypic description of transferrin receptor 2 knockout mouse, and role of hepcidin. Gut 2005;54:980-6.
4. Wallace DF, Summerville L, Subramaniam VN. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology 2007;132:301-10.
5. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 2008;9:72-81.
6. Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 2004;104:4287-92.
7. Robb A, Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 2004;104:4287-93.
8. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sides Y, Samad YA, et al. Bone morphogenetic protein signalling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-7.
9. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 2005;105:1803-6.
10. Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-60.
11. Barisani D, Pelucchi S, Mariani R, Galimberti S, Trombini P, Fumagalli D, et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload. J Hepatol 2008;49:123-33.
12. Bozzini C, Campostrini N, Trombini P, Nemeth E, Castagna A, Tenuti I, et al. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis 2008;40:347-52.
13. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, et al. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 2007;110:4096-100.
14. Deugnier YM, Loreal O, Turlin BD, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-9.
15. Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-62.
16. Wallace DF, Summerville L, Crampton EM, Subramaniam VN. Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis. Am J Physiol Cell Physiol 2008;294:C383-90.
17. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Int Med 1997;127:105-10.
18. Lainé F, Jouannolle AM, Morcet J, Brigand A, Pouchard M, Lafraise B, et al. Phenotypic expression in detected C282Y homozygous women depends on body mass index. J Hepatol 2005;43:1055-9.
19. Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005;129:1937-43.
20. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
21. Goswami T and Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006;28:28494-8.
22. Krijt J, Vokurka M, K Chang K-Y and E Necas E. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 2004;104:4308-10.
23. Muckenthaler MU. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 2008;8:1-3.
24. Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008;111:5195-204.